Autologous serum eardrops therapy for closing tympanic membrane perforations
Not Applicable
Completed
- Conditions
- internal otitis
- Registration Number
- JPRN-jRCTs031180262
- Lead Sponsor
- Kakehata Seiji
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with tympanic membrane perforation
Exclusion Criteria
otitis media or otitis externa
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tympanic membrane closure rate
- Secondary Outcome Measures
Name Time Method Hearing improvement
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie autologous serum eardrops in promoting tympanic membrane healing?
How does autologous serum eardrops therapy compare to standard-of-care treatments for tympanic membrane perforations in terms of efficacy and healing time?
Are there specific biomarkers that can predict patient response to autologous serum eardrops for tympanic membrane perforations?
What are the potential adverse events associated with autologous serum eardrops therapy for internal otitis and how can they be managed?
What related compounds or combination therapies are being explored for tympanic membrane repair in otitis studies?